On the other hand, cisplatin-resistant HNSCC cells exhibit an enhanced EMT phenotype, which is induced by CD44 via upregulating ZEB1 and suppressing microRNA-200c [126]. This evidence concerns the gene CD44 and head and neck squamous cell carcinoma.